Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.

Source:http://linkedlifedata.com/resource/pubmed/id/18954937

Download in:

View as

General Info

PMID
18954937